Genmab A (GMAB) Change in Taxes (2023 - 2026)

Genmab A has reported Change in Taxes for 4 years, with the latest figure at -$95.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Taxes fell 102.13% year-over-year to -$95.0 million; the trailing twelve-month figure through Mar 2026 stood at -$774.0 million (down 301.04% YoY), and the FY2025 full-year result was -$460.0 million, down 820.0% from the prior year.
• Change in Taxes for Q1 2026 stood at -$95.0 million, up from -$317.0 million in the prior quarter.
• The five-year high for Change in Taxes was -$47.0 million in Q1 2024, with the low at -$317.0 million in Q3 2025.
• Historically, Change in Taxes has averaged -$124.7 million across 4 years, with a median of -$50.0 million in 2024.
• Annual changes were most pronounced in 2024 — Change in Taxes jumped 67.74% — and 2025, when it tumbled 570.21%.
• Genmab A's Change in Taxes stood at -$155.0 million in 2023, then soared by 67.74% to -$50.0 million in 2024, then slumped by 534.0% to -$317.0 million in 2025, then surged by 70.03% to -$95.0 million in 2026.
• The last three Change in Taxes figures came in at -$95.0 million (Q1 2026), -$317.0 million (Q3 2025), and -$315.0 million (Q2 2025), per Business Quant data.